Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is June 12, 2024.
All times in Eastern Daylight Time.
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 11.06.2024 UIGB IE00079WNSI6 1,002.00 GBP 21,882.8... more »
-
Alliance of Comprehensive Planners (ACP) Shares Details on 2024 Annual ConferenceWILMINGTON, N.C.--(BUSINESS WIRE)--The Alliance of Comprehensive Planners (ACP), a community of tax-focused, fiduciary financial advisors who provide comprehensive wealth building strategies for th... more »
-
Brightside Health Expands into Substance Use Disorder, Virtual Intensive Outpatient TreatmentSAN FRANCISCO--(BUSINESS WIRE)--Brightside Health now offers virtual intensive outpatient programs (IOP) for substance use disorder (SUD). more »
-
CHICAGO--(BUSINESS WIRE)--Pritzker Private Capital (“PPC”), a leader in family direct investing, today announced that Anna Edgcomb has rejoined the firm as Vice President – Manufactured Products an... more »
-
TeachMe.To Names Tyler Maloney CEOSAN DIEGO--(BUSINESS WIRE)--TeachMe.To, the hub for finding and booking local in-person sports and skills instruction, today announced that it has named Tyler Maloney as Chief Executive Officer. Ni... more »
-
CASTLE ROCK, Colo.--(BUSINESS WIRE)--Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot”) today commented on the shareholder rights plan (the “Poison Pill”) unilaterally adopted by Bitfarms Ltd. (NASDAQ/TS... more »
-
BioStrand, filiale d’ImmunoPrecise Antibodies Ltd., reçoit le prestigieux prix Impact 2024 pour sa technologie LENSai™ révolutionnaireVICTORIA, Colombie-Britannique--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ : IPA) (“ImmunoPrecise” ou “IPA” ou la “Société”), un chef de file de la recherche et des technologies biothér... more »
-
F5 Study: Enterprises Plowing Ahead with AI Deployment Despite Gaps in Data Governance and Security ConcernsSEATTLE--(BUSINESS WIRE)--F5 (NASDAQ: FFIV) today released a new report that provides a unique view into the current state of enterprise AI adoption. F5’s 2024 State of AI Application Strategy Repo... more »
-
DUBLIN--(BUSINESS WIRE)-- TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN IE0001827041 Issuer Name CRH PLC UK or Non-UK Issuer Non-UK 2. Reason for Notification An ac... more »
-
25 Meat and Seafood Companies Enter the Queue for ReposiTrak’s Expanding Traceability NetworkSALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE:TRAK), the world’s largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock re... more »
-
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ TechnologyVICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), a leader in AI-driven biotherapeutic research and technology, t... more »
-
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-m... more »
-
GSK Enters Into a Multi-Year Data Licence Agreement With Ochre Bio to Further Investigate the Drivers of Liver DiseaseOXFORD, England--(BUSINESS WIRE)--Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership ... more »
-
N‑able Honored with Three Stevies at the 2024 American Business Awards®BURLINGTON, Mass.--(BUSINESS WIRE)--N-able, Inc. (NYSE: NABL), a global software company helping IT services providers deliver remote monitoring and management, data protection as-a-service, and se... more »
-
Foundation Medicine Announces Partnership with Repare Therapeutics to Provide Genomic Profiling Services to Support Clinical Trials and to Develop Companion Diagnostic for LunresertibBOSTON--(BUSINESS WIRE)--Foundation Medicine announces a collaboration with Repare Therapeutics to provide genomic profiling for Repare’s ongoing Phase I/Ib MYTHIC study. more »